NEW YORK - May 26, 2021 - The program for TVT 2021: The Structural Heart Summit is now available online. An annual meeting from the Cardiovascular Research Foundation (CRF), TVT features cutting-edge research and techniques for structural heart interventions. TVT will take place online and in person, with limited attendance, at the Fontainebleau Miami Beach in Miami Beach, Florida July 20-22, 2021.
"Transcatheter valve therapy is a growing treatment option for patients with valvular heart disease," said Martin B. Leon, MD, TVT Course Director. "The development of transcatheter aortic valve replacement (TAVR) and the adoption of transcatheter mitral and tricuspid therapies have transformed the treatment landscape, expanding options for patients with structural heart disease."
The treatment of structural heart disease is multidisciplinary, integrating noninvasive cardiac imaging, surgical therapies, heart failure management, and novel transcatheter approaches. TVT will focus on the evaluation and management of patients, imaging modalities, current and future therapeutic options, and skills needed to perform TAVR, left atrial appendage (LAA) closure, and patent foramen ovale (PFO) closure.
"We're excited to bring together again innovators involved in the structural heart field for three days of world-class education, training, and networking," said Juan F. Granada, MD, CRF's President and Chief Executive Officer and TVT Course Director. "This year's TVT course will be more inclusive, flexible, and accessible than ever before with countless opportunities for participants to elevate their skill sets and connect with thought leaders and colleagues from all over the globe."
TVT 2021 will feature 24 live cases from leading academic medical centers, 10 Master Class sessions focused on technique and procedural decision-making process, nine device-specific training opportunities, late-breaking clinical science, and structural innovation sessions. For more than a decade, TVT has provided healthcare professionals with the latest advances, tools, and techniques for the treatment of valvular heart disease using nonsurgical procedures.
Additional information on TVT is available at https:/
The Cardiovascular Research Foundation (CRF) is one of the world's leading nonprofit organizations specializing in interventional cardiology innovation, research, and education. CRF is dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For over 30 years, CRF has helped accelerate medical breakthroughs and educated doctors on the latest treatments for heart disease. CRF's centers of excellence include the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team. For more information, visit http://www.